My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 106

    1.

    The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users.

    Norman J, Walsh NM, Mugavin J, Stoové MA, Kelsall J, Austin K, Lintzeris N.

    Harm Reduct J. 2008 Feb 25;5:8.PMID: 18298862 [PubMed - in process]Related articlesFree article

    2.

    Integrating HCV services for drug users: a model to improve engagement and outcomes.

    Sylvestre DL, Zweben JE.

    Int J Drug Policy. 2007 Oct;18(5):406-10. Epub 2007 Apr 30.PMID: 17854729 [PubMed - indexed for MEDLINE]Related articles

    3.

    A primary care based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C.

    Jack K, Willott S, Manners J, Varnam MA, Thomson BJ.

    Aliment Pharmacol Ther. 2008 Oct 11. [Epub ahead of print]PMID: 18945252 [PubMed - as supplied by publisher]Related articles

    4.

    Acceptability of hepatitis C virus testing methods among injecting drug users.

    White B, Day C, Thein HH, Doab A, Bates A, Holden J, van Beek I, Maher L.

    Drug Alcohol Rev. 2008 Nov;27(6):666-70.PMID: 19378449 [PubMed - indexed for MEDLINE]Related articles

    5.

    Hepatitis services at an injecting drug user outreach clinic.

    Moriarty H, Kemp R, Robinson G.

    N Z Med J. 2001 Mar 23;114(1128):105-6.PMID: 11346154 [PubMed - indexed for MEDLINE]Related articles

    6.

    Acceptability of hepatitis C virus testing methods among injecting drug users.

    White B, Day C, Thein HH, Doab A, Bates A, Holden J, van Beek I, Maher L.

    Drug Alcohol Rev. 2008 Mar 31:1-5. [Epub ahead of print]PMID: 18608455 [PubMed - as supplied by publisher]Related articles

    7.

    Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.

    Miller ER, Hellard ME, Bowden S, Bharadwaj M, Aitken CK.

    J Infect. 2009 May;58(5):375-82. Epub 2009 Mar 27.PMID: 19328555 [PubMed - indexed for MEDLINE]Related articles

    8.

    Developing a nursing service for patients with hepatitis C.

    Fahey S.

    Nurs Stand. 2007 Jul 4-10;21(43):35-40.PMID: 17695583 [PubMed - indexed for MEDLINE]Related articles

    9.

    Broadening discussions of "safe" in hepatitis C prevention: a close-up of swabbing in an analysis of video recordings of injecting practice.

    Treloar C, Laybutt B, Jauncey M, van Beek I, Lodge M, Malpas G, Carruthers S.

    Int J Drug Policy. 2008 Feb;19(1):59-65. Epub 2007 Feb 12.PMID: 18312820 [PubMed - indexed for MEDLINE]Related articles

    10.

    Evaluation of a general practice based hepatitis C virus screening intervention.

    Anderson EM, Mandeville RP, Hutchinson SJ, Cameron SO, Mills PR, Fox R, Ahmed S, Taylor A, Spence E, Goldberg DJ.

    Scott Med J. 2009 Aug;54(3):3-7.PMID: 19728405 [PubMed - indexed for MEDLINE]Related articles

    11.

    The development of peer educator-based harm reduction programmes in Northern Vietnam.

    Walsh N, Gibbie TM, Higgs P.

    Drug Alcohol Rev. 2008 Mar;27(2):200-3.PMID: 18264883 [PubMed - indexed for MEDLINE]Related articles

    12.

    Australia's public health response to HIV and HCV: a role for 'affected' communities.

    Hulse GK.

    Drug Alcohol Rev. 1997 Jun;16(2):171-6.PMID: 16203423 [PubMed]Related articles

    13.

    Modelling and calibration of the hepatitis C epidemic in Australia.

    Razali K, Amin J, Dore GJ, Law MG, HCV Projections Working Group.

    Stat Methods Med Res. 2009 Jun;18(3):253-70. Epub 2008 Nov 26.PMID: 19036911 [PubMed - indexed for MEDLINE]Related articles

    14.

    Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.

    Munoz-Plaza CE, Strauss S, Astone-Twerell J, Jarlais DD, Gwadz M, Hagan H, Osborne A, Rosenblum A.

    Int J Drug Policy. 2008 Feb;19(1):71-8. Epub 2007 Aug 6.PMID: 18312822 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.

    Xia X, Luo J, Bai J, Yu R.

    Public Health. 2008 Oct;122(10):990-1003. Epub 2008 May 19. Review.PMID: 18486955 [PubMed - indexed for MEDLINE]Related articles

    16.

    Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.

    Treloar C, Newland J, Rance J, Hopwood M.

    J Viral Hepat. 2010 Jan 13. [Epub ahead of print]PMID: 20070504 [PubMed - as supplied by publisher]Related articles

    17.

    The social production of hepatitis C risk among injecting drug users: a qualitative synthesis.

    Rhodes T, Treloar C.

    Addiction. 2008 Oct;103(10):1593-603. Review.PMID: 18821870 [PubMed - indexed for MEDLINE]Related articles

    18.

    Integrating enhanced hepatitis C testing and counselling in research.

    Winter R, Nguyen O, Higgs P, Armstrong S, Duong D, Thach ML, Aitken C, Hellard M.

    Int J Drug Policy. 2008 Feb;19(1):66-70. Epub 2007 Jun 20.PMID: 18312821 [PubMed - indexed for MEDLINE]Related articles

    19.

    Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.

    Loebstein R, Mahagna R, Maor Y, Kurnik D, Elbaz E, Halkin H, Olchovsky D, Ezra D, Almog S.

    Isr Med Assoc J. 2008 Nov;10(11):775-8.PMID: 19070285 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.

    Vicknasingam B, Narayanan S, Navaratnam V.

    Drug Alcohol Rev. 2009 Jul;28(4):447-54.PMID: 19594801 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk